Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Meet our Quality Assurance and Regulatory Affairs Director in the latest edition of our newsletter… https://t.co/2TvV9bz4W6
27 June 2017
© Abingdon Health 2017